Patents by Inventor Takashi Imada
Takashi Imada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240132519Abstract: Compounds represented by formula (I), compounds of the less-polar group of two groups of diastereomers in which the carbon atom indicated by * in formula (II) is an asymmetric carbon atom, salts of the compounds, and solvates of the compounds or salts. The compounds have Nrf2 activating action.Type: ApplicationFiled: December 28, 2021Publication date: April 25, 2024Applicant: SENJU PHARMACEUTICAL CO., LTD.Inventors: Tomoyo MIYABE, Shinnosuke MACHIDA, Yuka OBA, Masaki KAKEHI, Takashi IMADA, Takeshi NAKAJIMA
-
Publication number: 20240127946Abstract: An information processing device of this embodiment includes a communication unit configured to communicates with a first terminal device and a second terminal device, the first terminal device being held by a medical caregiver, the second terminal device being held by a care assistant and a processing unit configured to acquire a medical information and a care assistance information, the medical information including a first method how to deal with a diagnosis of a patient taken by the medical caregiver, the care assistance including a second method how to deal with a status of the patient taken by the care assistant through the communication unit, wherein the processing unit is configured to provide the medical information and the care assistance information in association with the patient on the first terminal device and the second terminal device.Type: ApplicationFiled: July 24, 2023Publication date: April 18, 2024Applicant: PARAMOUNT BED CO., LTD.Inventors: Takashi Ishikawa, Yuuki Nakamura, Yutaka Imada
-
Publication number: 20230390235Abstract: The present invention aims to develop a method for treating COVID-19 caused by SARS-CoV-2 or a mutant strain thereof, and provides an agent for preventing and/or treating COVID-19 caused by SARS-CoV-2 or a mutant strain thereof, the agent comprising a specific compound.Type: ApplicationFiled: October 29, 2021Publication date: December 7, 2023Applicants: SENJU PHARMACEUTICAL CO., LTD., TOHOKU UNIVERSITYInventors: Mitsuyoshi AZUMA, Chiho FUKIAGE, Takashi IMADA, Yayoi KISHIMOTO, Noriyasu HIRASAWA, Yoshiro SAITO, Takashi TOYAMA
-
Publication number: 20230182644Abstract: Provided is a structure that makes it possible to reduce the number of components. The present invention provides a structure including a resin-molded body and a torsion spring. The resin-molded body includes a front wall and a rear wall spaced apart from each other and a peripheral wall connecting peripheries of the front wall and the rear wall. The resin-molded body includes first and second plate-shaped portions and a hinge portion. The first and second plate-shaped portions are rotatably coupled to each other with the hinge portion. The hinge portion is formed by making the rear wall concave toward the front wall to form a hinge concave portion and welding the rear wall to the front wall. The torsion spring includes first and second arms and a coil portion provided therebetween. The first arm is slidably supported by the first plate-shaped portion. The second arm is supported by the second plate-shaped portion.Type: ApplicationFiled: April 21, 2021Publication date: June 15, 2023Applicants: KYORAKU CO., LTD., HAYASHI TELEMPU CORPORATIONInventors: Masaaki SUEOKA, Ryuichi ISHIDA, Takashi IMADA, Katsuki TANAKA, Kenta SUZUKI
-
Publication number: 20180319812Abstract: The present invention relates to compound (I) or a salt thereof which has a ROR?t inhibitory action. wherein each symbol is as defined in the specification.Type: ApplicationFiled: July 13, 2018Publication date: November 8, 2018Inventors: Satoshi Yamamoto, Junya Shirai, Hiroyuki Watanabe, Shoji Fukumoto, Tsuneo Oda, Hidekazu Tokuhara, Yoshihide Tomata, Naoki Ishii, Michiko Tawada, Mitsunori Kono, Atsuko Ochida, Takashi Imada, Yoshiyuki Fukase, Tomoya Yukawa
-
Patent number: 10093629Abstract: Provided are heterocyclic compounds having a ROR?t inhibitory action represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.Type: GrantFiled: June 30, 2015Date of Patent: October 9, 2018Assignee: Takeda Pharmaceutical Company LimitedInventors: Satoshi Yamamoto, Junya Shirai, Tsuneo Oda, Mitsunori Kono, Atsuko Ochida, Takashi Imada, Hidekazu Tokuhara, Yoshihide Tomata, Naoki Ishii, Michiko Tawada, Yoshiyuki Fukase, Tomoya Yukawa, Shoji Fukumoto
-
Patent number: 10053468Abstract: The present invention relates to compound (I) or a salt thereof which has a ROR?t inhibitory action. wherein each symbol is as defined in the specification.Type: GrantFiled: July 2, 2014Date of Patent: August 21, 2018Assignee: Takeda Pharmaceutical Company LimitedInventors: Satoshi Yamamoto, Junya Shirai, Hiroyuki Watanabe, Shoji Fukumoto, Tsuneo Oda, Hidekazu Tokuhara, Yoshihide Tomata, Naoki Ishii, Michiko Tawada, Mitsunori Kono, Atsuko Ochida, Takashi Imada, Yoshiyuki Fukase, Tomoya Yukawa
-
Patent number: 10000488Abstract: The problem of the present invention is to provide a compound having a superior ROR?t inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like. The present invention relates to a compound represented by the formula (I): [wherein each symbol is as described in the DESCRIPTION] or a salt thereof, which has an ROR?t inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.Type: GrantFiled: September 10, 2015Date of Patent: June 19, 2018Assignee: Takeda Pharmaceutical Company LimitedInventors: Satoshi Yamamoto, Junya Shirai, Tsuneo Oda, Takashi Imada, Mitsunori Kono, Ayumu Sato, Yoshihide Tomata, Atsuko Ochida, Naoki Ishii, Yusuke Sasaki, Yoshiyuki Fukase, Tomoya Yukawa, Shoji Fukumoto
-
Publication number: 20170253591Abstract: The problem of the present invention is to provide a compound having a superior ROR?t inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like. The present invention relates to a compound represented by the formula (I): [wherein each symbol is as described in the DESCRIPTION] or a salt thereof, which has an ROR?t inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.Type: ApplicationFiled: September 10, 2015Publication date: September 7, 2017Inventors: Satoshi YAMAMOTO, Junya SHIRAI, Tsuneo ODA, Takashi IMADA, Mitsunori KONO, Ayumu SATO, Yoshihide TOMATA, Atsuko OCHIDA, Naoki ISHII, Yusuke SASAKI, Yoshiyuki FUKASE, Tomoya YUKAWA, Shoji FUKUMOTO
-
Publication number: 20170144973Abstract: Provided are heterocyclic compounds having a ROR?t inhibitory action represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.Type: ApplicationFiled: June 30, 2015Publication date: May 25, 2017Applicant: Takenda Pharmaceutical Company LimitedInventors: Satoshi YAMAMOTO, Junya SHIRAI, Tsuneo ODA, Mitsunori KONO, Atsuko OCHIDA, Takashi IMADA, Hidekazu TOKUHARA, Yoshihide TOMATA, Naoki ISHII, Michiko TAWADA, Yoshiyuki FUKASE, Tomoya YUKAWA, Shoji FUKUMOTO
-
Patent number: 9650343Abstract: The present invention provides a heterocyclic compound having a ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.Type: GrantFiled: February 26, 2016Date of Patent: May 16, 2017Assignee: Takeda Pharmaceutical Company LimitedInventors: Satoshi Yamamoto, Junya Shirai, Tsuneo Oda, Mitsunori Kono, Atsuko Ochida, Takashi Imada, Hidekazu Tokuhara, Yoshihide Tomata, Naoki Ishii, Michiko Tawada, Yoshiyuki Fukase, Tomoya Yukawa, Shoji Fukumoto
-
Patent number: 9630924Abstract: The present invention provides a heterocyclic compound having a ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.Type: GrantFiled: February 26, 2016Date of Patent: April 25, 2017Assignee: Takeda Pharmaceutical Company LimitedInventors: Satoshi Yamamoto, Junya Shirai, Tsuneo Oda, Mitsunori Kono, Atsuko Ochida, Takashi Imada, Hidekazu Tokuhara, Yoshihide Tomata, Naoki Ishii, Michiko Tawada, Yoshiyuki Fukase, Tomoya Yukawa, Shoji Fukumoto
-
Publication number: 20170050974Abstract: The present invention relates to compound (I) or a salt thereof which has a ROR?t inhibitory action. wherein each symbol is as defined in the specification.Type: ApplicationFiled: July 2, 2014Publication date: February 23, 2017Inventors: Satoshi Yamamoto, Junya Shirai, Hiroyuki Watanabe, Shoji Fukumoto, Tsuneo Oda, Hidekazu Tokuhara, Yoshihide Tomata, Naoki Ishii, Michiko Tawada, Mitsunori Kono, Atsuko Ochida, Takashi Imada, Yoshiyuki Fukase, Tomoya Yukawa
-
Patent number: 9573903Abstract: The present invention provides a heterocyclic compound having a ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.Type: GrantFiled: February 26, 2016Date of Patent: February 21, 2017Assignee: Takeda Pharmaceutical Company LimitedInventors: Satoshi Yamamoto, Junya Shirai, Tsuneo Oda, Mitsunori Kono, Atsuko Ochida, Takashi Imada, Hidekazu Tokuhara, Yoshihide Tomata, Naoki Ishii, Michiko Tawada, Yoshiyuki Fukase, Tomoya Yukawa, Shoji Fukumoto
-
Publication number: 20160229814Abstract: The present invention provides a heterocyclic compound having an ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein Ar is a the partial structure (1) to the partial structure (5), Q is a bivalent group selected from the group consisting of (Ia)-(If), and B is a ring optionally having substituent(s), or a salt thereof.Type: ApplicationFiled: March 13, 2014Publication date: August 11, 2016Inventors: Satoshi Yamamoto, Junya Shirai, Yoshiyuki Fukase, Ayumu Sato, Mitsunori Kouno, Yoshihide Tomata, Atsuko Ochida, Kazuko Yonemori, Tsuneo Oda, Takashi Imada, Tomoya Yukawa
-
Publication number: 20160176873Abstract: The present invention provides a heterocyclic compound having a ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.Type: ApplicationFiled: February 26, 2016Publication date: June 23, 2016Inventors: Satoshi YAMAMOTO, Junya SHIRAI, Tsuneo ODA, Mitsunori KONO, Atsuko OCHIDA, Takashi IMADA, Hidekazu TOKUHARA, Yoshihide TOMATA, Naoki ISHII, Michiko TAWADA, Yoshiyuki FUKASE, Tomoya YUKAWA, Shoji FUKUMOTO
-
Publication number: 20160176822Abstract: The present invention provides a heterocyclic compound having a ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.Type: ApplicationFiled: February 26, 2016Publication date: June 23, 2016Inventors: Satoshi YAMAMOTO, Junya SHIRAI, Tsuneo ODA, Mitsunori KONO, Atsuko OCHIDA, Takashi IMADA, Hidekazu TOKUHARA, Yoshihide TOMATA, Naoki ISHII, Michiko TAWADA, Yoshiyuki FUKASE, Tomoya YUKAWA, Shoji FUKUMOTO
-
Publication number: 20160176872Abstract: The present invention provides a heterocyclic compound having a ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.Type: ApplicationFiled: February 26, 2016Publication date: June 23, 2016Inventors: Satoshi YAMAMOTO, Junya SHIRAI, Tsuneo ODA, Mitsunori KONO, Atsuko OCHIDA, Takashi IMADA, Hidekazu TOKUHARA, Yoshihide TOMATA, Naoki ISHII, Michiko TAWADA, Yoshiyuki FUKASE, Tomoya YUKAWA, Shoji FUKUMOTO
-
Patent number: 9365520Abstract: The present invention provides a heterocyclic compound having a ROR?t inhibitory action. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.Type: GrantFiled: June 30, 2015Date of Patent: June 14, 2016Assignee: Takeda Pharmaceutical Company LimitedInventors: Satoshi Yamamoto, Junya Shirai, Tsuneo Oda, Mitsunori Kono, Atsuko Ochida, Takashi Imada, Hidekazu Tokuhara, Yoshihide Tomata, Naoki Ishii, Michiko Tawada, Yoshiyuki Fukase, Tomoya Yukawa, Shoji Fukumoto
-
Patent number: 9346822Abstract: The present invention provides a compound represented by the formula: wherein R1 is a C1-4 alkyl; R2 is (1) a 5- to 7-membered nitrogen-containing heterocyclic group which may have a substituent selected from the group consisting of (1?) a halogen, (2?) a hydroxy group, (3?) a C1-4 alkyl and (4?) a C1-4 alkoxy, (2) a phenyl which may have a substituent selected from the group consisting of (1?) a halogen, (2?) a C1-4 alkoxy-C1-4 alkyl, (3?) a mono-C1-4 alkyl-carbamoyl-C1-4 alkyl, (4?) a C1-4 alkoxy and (5?) a mono-C1-4 alkylcarbamoyl-C1-4 alkoxy, or the like; R3 is a C1-4 alkyl; R4 is a C1-4 alkoxy, or the like; n is an integer of 1 to 4; or a salt thereof, as a thienopyrimidine compound having gonadotropin-releasing hormone antagonistic activity.Type: GrantFiled: April 11, 2014Date of Patent: May 24, 2016Assignee: Takeda Pharmaceutical Company LimitedInventors: Nobuo Cho, Takashi Imada, Takenori Hitaka, Kazuhiro Miwa, Masami Kusaka, Nobuhiro Suzuki